Patents by Inventor Robert Sanchez
Robert Sanchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170143534Abstract: A container for collecting liquid for transport, comprising: a web of flexible porous material defining at least a portion of a chamber in which liquid can be collected for transport. The chamber is configured to receive a tube in a position within the chamber that enables the tube to transport liquid from the chamber while the liquid collects within the chamber upon being drawn through the web when a partial vacuum is applied within the chamber via the tube. The porous material comprises a web of spun plastic fibers, such as spun polyester fibers. In one embodiment, the web of spun plastic fibers is configured to define an elongated portion of the chamber. In another embodiment, a backing of non-permeable material covers a portion of the web and is so combined with the web as to further define the chamber.Type: ApplicationFiled: November 25, 2015Publication date: May 25, 2017Applicant: PureWick CorporationInventor: Robert A. Sanchez
-
Publication number: 20170112844Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: September 3, 2015Publication date: April 27, 2017Inventors: Rosanna TEDESCO, Junya QU, Robert SANCHEZ, Ralph A. RIVERO
-
Patent number: 9615970Abstract: An intraocular pressure sensor system has a first pressure sensor located in an anterior chamber of an eye and a remote pressure sensor located remotely from the first pressure sensor. The remote pressure sensor measures or approximates atmospheric pressure. A difference between readings from the first pressure sensor and the remote pressure sensor approximates intraocular pressure.Type: GrantFiled: May 1, 2014Date of Patent: April 11, 2017Assignee: Alcon Research, Ltd.Inventors: Matthew Rickard, Robert Sanchez, Jr.
-
Patent number: 9603742Abstract: A system for implantation in an eye of a patient includes a flow device sized for implantation into the eye of the patient. The flow device includes a fluid flow passageway and a flow system. The flow system may include a regulator having a magnetic element, and may be displaceable in the fluid flow passageway to affect flow through the fluid flow passageway. The system may also include a control device physically separate from the flow device and configured to be disposed outside the eye, the control device comprising an actuator magnetic field generator configured to act on the magnetic element to adjust the regulator in the flow system to selectively adjust flow through the flow device in response to changes in intraocular pressure.Type: GrantFiled: March 13, 2014Date of Patent: March 28, 2017Assignee: Novartis AGInventors: Robert Sanchez, Casey Lind
-
Patent number: 9560959Abstract: Control of scanning images during ophthalmic surgery may be performed with a scanning controller that interfaces to an optical scanner used with a surgical microscope. A scan control device may receive user input, including hands-free user input, for controlling an overlay image of scanning data that is overlaid on optical image data viewed using the surgical microscope. A selected location for optical scanning may also be displayed and controlled using the scanning controller.Type: GrantFiled: September 18, 2015Date of Patent: February 7, 2017Assignee: Novartis AGInventors: Mark Hopkins, Robert Sanchez, Ryan Takakawa, Lingfeng Yu, Hugang Ren
-
Publication number: 20160374848Abstract: A system suitable for collecting and transporting urine away from the body of a person or animal may include an assembly having a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the reservoir and the outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and a second, fluid discharge end.Type: ApplicationFiled: September 8, 2016Publication date: December 29, 2016Applicant: PUREWICK CORPORATIONInventors: Robert A. SANCHEZ, Camille R. NEWTON, Joseph M. FOREHAND, Raymond J. NEWTON
-
Publication number: 20160278983Abstract: Apparatuses, systems, and methods for treating tissue abnormalities are disclosed. The tissue may be visualized for determining a presence of one or more abnormalities contained therein. Imaging data obtained by visualization may be used to determine the presence of one or more abnormalities. Each of the detected abnormalities may be identified and a treatment plan developed for treating the abnormalities. Treatment may be delivered to the abnormalities according to the treatment plan.Type: ApplicationFiled: February 23, 2016Publication date: September 29, 2016Inventors: Michael John Claus, Robert Sanchez, Tammo Heeren, Argelio Michael Olivera, Michael Papac, Lingfeng Yu, Hugang Ren
-
Patent number: 9295389Abstract: An IOP monitoring device for implantation in an eye of a patient may include a first tube having a first opening, the first tube being configured to extend into the anterior chamber. An intraocular pressure sensing (IOP) device for implantation in an eye of a patient may include a pressure sensor, a pressure sensor cap, and a tube coupled to a chamber inlet. The pressure sensor cap may include a recess having an inner surface, the recess configured to receive the pressure sensor such that a chamber is formed by the pressure sensor and the inner surface and a chamber inlet permitting a fluid to communicate with the chamber and be primed in a bubble-free manner. The tube may be coupled to the chamber inlet to allow fluid communication between an anterior chamber of the eye and the chamber.Type: GrantFiled: December 3, 2013Date of Patent: March 29, 2016Assignee: Novartis AGInventors: Robert Sanchez, Michael Morelli, Alex G. Fermin, Michael LeRoy Gelvin
-
Patent number: 9156797Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: GrantFiled: May 15, 2015Date of Patent: October 13, 2015Assignee: GlaxoSmithKline LLCInventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Publication number: 20150257931Abstract: A system for implantation in an eye of a patient includes a flow device sized for implantation into the eye of the patient. The flow device includes a fluid flow passageway and a flow system. The flow system may include a regulator having a magnetic element, and may be displaceable in the fluid flow passageway to affect flow through the fluid flow passageway. The system may also include a control device physically separate from the flow device and configured to be disposed outside the eye, the control device comprising an actuator magnetic field generator configured to act on the magnetic element to adjust the regulator in the flow system to selectively adjust flow through the flow device in response to changes in intraocular pressure.Type: ApplicationFiled: March 13, 2014Publication date: September 17, 2015Applicant: Alcon Research, Ltd.Inventors: Robert Sanchez, Casey Lind
-
Publication number: 20150246889Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: May 15, 2015Publication date: September 3, 2015Inventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Patent number: 9062003Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: GrantFiled: September 9, 2014Date of Patent: June 23, 2015Assignee: GlaxoSmithKline LLCInventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Publication number: 20140378456Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: September 9, 2014Publication date: December 25, 2014Inventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Patent number: 8865912Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: GrantFiled: January 27, 2014Date of Patent: October 21, 2014Assignee: GlaxoSmithKline LLCInventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Patent number: 8821440Abstract: An injection device has a dispensing chamber housing, a plunger, and a temperature control device. The dispensing chamber housing has a first part and a second part. The first part is thermally coupled to a needle. The second part is thermally coupled to the first part. The second part has an inner surface and an outer surface. The inner surface partially defines a dispensing chamber for holding a quantity of a substance. The plunger is engaged with an inner surface of the dispensing chamber housing, is capable of sliding in the dispensing chamber housing, and is fluidly sealed to the inner surface of the dispensing chamber housing. The temperature control device at least partially surrounds the dispensing chamber housing and is capable of altering a temperature of the substance in the dispensing chamber. The second part has a greater thermal coefficient than the first part.Type: GrantFiled: July 13, 2007Date of Patent: September 2, 2014Assignee: Alcon Research, Ltd.Inventors: Robert Sanchez, James Foster, Cesario Dos Santos
-
Publication number: 20140243731Abstract: An intraocular pressure sensor system has a first pressure sensor located in an anterior chamber of an eye and a remote pressure sensor located remotely from the first pressure sensor. The remote pressure sensor measures or approximates atmospheric pressure. A difference between readings from the first pressure sensor and the remote pressure sensor approximates intraocular pressure.Type: ApplicationFiled: May 1, 2014Publication date: August 28, 2014Applicant: ALCON RESEARCH, LTD.Inventors: MATTHEW RICKARD, ROBERT SANCHEZ, JR.
-
Publication number: 20140171777Abstract: An IOP monitoring device for implantation in an eye of a patient may include a first tube having a first opening, the first tube being configured to extend into the anterior chamber. An intraocular pressure sensing (IOP) device for implantation in an eye of a patient may include a pressure sensor, a pressure sensor cap, and a tube coupled to a chamber inlet. The pressure sensor cap may include a recess having an inner surface, the recess configured to receive the pressure sensor such that a chamber is formed by the pressure sensor and the inner surface and a chamber inlet permitting a fluid to communicate with the chamber and be primed in a bubble-free manner. The tube may be coupled to the chamber inlet to allow fluid communication between an anterior chamber of the eye and the chamber.Type: ApplicationFiled: December 3, 2013Publication date: June 19, 2014Applicant: Alcon Research, Ltd.Inventors: Robert Sanchez, Michael Morelli, Alex G. Fermin, Michael LeRoy Gelvin
-
Publication number: 20140142321Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: January 27, 2014Publication date: May 22, 2014Applicant: GlaxoSmithKline LLCInventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Patent number: 8674090Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: GrantFiled: September 19, 2013Date of Patent: March 18, 2014Assignee: GlaxoSmithKline LLCInventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Publication number: 20140018534Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: September 19, 2013Publication date: January 16, 2014Applicant: GlaxoSmithKline LLCInventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco